Gene Query: AQP3

Dataset Description Geneva Score
IRF2 is a master regulator of human keratinocyte stem cell fate 136.76
IRF2 is a master regulator of human keratinocyte stem cell fate [RNA-seq] 136.76
Genome-wide analysis of YAP and TFCP2 down-regulated genes in liver cancer cells 115.27
Genome-wide analysis of YAP and TFCP2 occupancy and regulated expression in liver cancer cells 115.27
GREB1, a novel target of Wnt signaling, promotes development of hepatoblastoma by suppressing TGFβ signaling 101.74
RNA-sequencing (RNA-seq) in BxPC-3 and S2-007 cell lines 88.49
Induction of human hemogenesis in adult fibroblasts by defined factors and hematopoietic co-culture 86.38
RNA sequence analysis of stable versus reversible EMT events and the resultant metastases 81.04
Novel Form of JARID2 is Required to Regulate Differentiation in Keratinocytes. 79.0
mRNA-seq from Nutlin-3a, doxorubicin, and DMSO treated HCT116 p21-/- cells 76.47
Quantitative Analysis of PPARD Transcriptomes in Colon Cancer Cells by Next Generation Sequencing (NGS) 74.67
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone [HCT RNA-Seq] 74.42
Transcriptome profiling of Cryptosporidium parvum infected lung and intestinal organoids 71.82
IL-1β induces the rapid secretion of the antimicrobial protein IL-26 from Th17 cells 70.63
Polyol pathway links glucose metabolism to the aggressiveness of cancer cells 64.14
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation (RNA-seq) 62.93
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation 62.93
A novel CD4+ T cell population expanded in SLE blood provides B cell help through IL10 and succinate 62.42
Phosphatase inhibitor PPP1R11 modulates resistance of human T cells towards Treg-mediated suppression of TCR signaling 62.3
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation 61.29
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation (Human_RWPE1_RNA-Seq) 61.29
Genome wide expression change by RNF168 knocking down in NEC cells 57.03
IDH3a KO RNA-seq 56.96
SILAC identifies LAD1 as an oncogenic filamin binder regulating actin dynamics in response to EGF and marking aggressive breast tumors 56.23
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung 54.78
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung [RNA-seq] 54.78
Treatment of multiple myeloma cells with EZH2 small molecule inhibitor 54.59
Developing a Novel Two-Dimensional Culture System to Enrich Human Prostate Luminal Progenitors That Can Function as a Cell of Origin for Prostate Cancer 53.54
3D genome of multiple myeloma reveals spatial genome disorganization associated with copy number variations 53.44
Splicing and epigenetic factors jointly regulate epidermal differentiation 52.93
Analysis Of The TGFb-Induced Program In Primary Airway Epithelial Cells Shows Essential Role Of NF-kB/RelA Signaling Network In Type II Epithelial Mesenchymal Transition 50.97
RNA-seq profile of expanded human ST2-transduced Tregs cultured with IL-2 and TCR in the presence or absence of IL-33 50.53
Next Generation Sequencing Facilitates Quantitative Analysis of HIV-1 Latency in Central Memory T Cells 50.51
Amiloride, an old diuretic drug, is a potential therapeutic agent for multiple myeloma 50.16
Aberrant downstream mechanisms following loss of KMT2C and KMT2D in Pancreatic Ductal Adenocarcinoma 48.97
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype [RNA-Seq] 48.65
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype 48.65
Statins modulate endothelial transcriptional profile by inhibiting EZH2 48.29
G-quadruplex structures mark human regulatory chromatin 46.44
H1609088 Human RNA-Sequencing 46.08
Alu RNA modulates the expression of cell cycle genes in human fibroblasts 44.95
Cajal bodies are linked to genome conformation 44.91
Cajal bodies are linked to genome conformation [RNA-Seq] 44.91
PR isoform-specific ER and PR chromatin binding and gene expression observed in-vitro in breast cancer cells. 44.77
BAF controls genome accessibility 44.06
Non-synchronized cell cycle transcriptomics in U2OS and HeLa cancer cells 43.52
Gene expression profiling study by RNA-seq for identifying genes associated with epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 43.24
Epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 43.24
Effect of selective glucocorticoid receptor modulation (SGRM) on gene expression in human prostate cancer cell lines 42.99
Transcriptome wide analysis of classically and alternatively activated macrophages 42.98
Modulation of gene transcription and epigenetics of colon carcinoma cells by bacterial membrane vesicles 42.56
Transcriptome analysis in HT29 and SW480 cells depleted of Prdx2 41.95
Next-generation RNA sequencing to determine changes in gene expression during breast cancer progression 41.75
Messenger RNA expression after silencing or inhibition of MEN1in MCF-7 breast cancer cells 41.24
Generation of induced keratinocyte stem cells from human urine cells by defined transcription factors 41.17
Valproic acid attenuates hyperglycemia induced complement and coagulation cascade gene expression 40.97
A novel lncRNA GAS1 promotes gastric carcinogenesis and acts as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern [RNA-seq] 40.69
ChIP-seq and RNA-seq in BGC823 cells after downregulation of GAS1 expression 40.69
The Role of Histone H3 Lysine 36 Methylation in Reprogramming of fibroblasts and on Induced Pluripotent stem Cell Generation 40.23
GRHL2 is a key lineage determining factor which collaborates with FOXA1 to establish a targetable collateral pathway in the setting of endocrine therapy-resistant breast cancer (RNA-Seq data set 1) 39.71
DNA damage signaling mediates the functional antagonism between replicative senescence and terminal muscle differentiation 39.54
A549 cells and MSR-A549 cells 39.42
mRNA expression profile of A549 cells and MSR-A549 cells with or without JQ1 treatment 39.42
MYOD Remodeling of the Genome Architecture during Myogenic Conversion of Somatic Cells 38.41
microRNA suppresses prostate cancer stem cells and metastasis by inhibiting a cohort of pro-metastasis targets including CD44, Rho GTPases and EZH2 38.25
Epigenetic Therapy Increases Therapeutic Efficacy in Myeloproliferative Neoplasms Through Inhibition of Aberrant Inflammatory Signaling 38.17
Gene Expression of Breast Cancer Cell Lines Across Biomaterial Platforms 37.87
Endometrial transcriptome and PGR cistrome in cycling fertile women 37.52
Endometrial transcriptome and PGR cistrome in cycling fertile women [RNA-seq] 37.52
MYOD Gene Expression Regulation during Myogenic Conversion of Fibroblasts 37.12
Depicting early human development and germ cell origin with porcine embryos 36.95
Gene expression analysis of immortalized human liver progenitor-like cells in culture 36.84
Transcriptome analysis of virus infected tissues 36.63
Bulk RNA-sequencing of cell types isolated by FACS from normal human prostates 36.62
Three-dimensional Oxabicycloheptene sulfonate targets the homologous recombination and repair programs through estrogen receptor α antagonism 36.5
Re-Wiring 3D Nuclear Architecture by a Single Transcription Factor during Somatic Cell Reprogramming 36.46
CD86 regulates a pro-survival signal in myeloma cells 35.7
Human induced pluripotent stem cell-derived vocal fold mucosa mimics development and responses to smoke exposure 35.68
mRNA cap methyltransferase, RNMT-RAM, promotes RNA pol II transcription 35.47
Gene expression alterations of pancreatic intraepithlial neoplasia 35.26
Dermal fibroblasts play a central role in skin model protection against C. albicans invasion 35.23
Gene-Centric Functional Dissection of Human Genetic Variation Uncovers Regulators of Hematopoiesis 35.0
Transcripotome analysis of different locations of hair follicles (bulb, bulge) in androgenetic alopecia 34.93
Transcriptomic and gene ontology profiling of the human corneal cell types 34.16
Expression analysis of genes modulated after knock-down of lncRNA CHROME. 34.03
Gene expression profile of multiple myeloma cell lines treated with CB-5083 33.4
Dermal endothelial cells of type 2 diabetic patients 33.07
Silencing p300 in MCF7 cells to study expression and alternative splicing 32.97
Transcriptional profiling of MCF7 cells treated with H3B05942, E2, or standard of care compounds 32.5
ELF1 expression in prostate cells reduces oncogenic ETS functions and promotes senescence and sensitivity to chemotherapy through distinct gene expression programs [RNA-seq] 32.39
ELF1 expression in prostate cells reduces oncogenic ETS functions and promotes senescence and sensitivity to chemotherapy through distinct gene expression programs 32.39
A pooled single-cell genetic screen identifies regulatory barriers in the continuum of the epithelial-to-mesenchymal transition 32.29
Circular RNAs are super abundant in cervical tumor and plasma detected by high throughput microarray 32.09
Circular RNAs are super abundant in cervical tumor and plasma detected by high throughput microarray [RNA-Seq] 32.09
Transcriptomic analysis of trametinib-resistant HCT116 colorectal carcinoma cells compared to the parental control cells 31.99
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator 31.63
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator [RNA-seq] 31.63
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 31.6
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 31.6
Transcriptomics analysis of gene expression in multiple human and mouse cells and tissues 31.56
Virus-like vesicles of Kaposi’s Sarcoma-Associated Herpesvirus activate lytic replication through triggering differentiation signaling (mRNA) 31.56
Virus-like vesicles of Kaposi’s Sarcoma-Associated Herpesvirus activate lytic replication through triggering differentiation signaling 31.56
Global analysis of ZNF217 chromatin occupancy in the breast cancer cell genome reveals an association with Eralpha 30.92
Integrin signaling regulates YAP/TAZ to control skin homeostasis 30.88
Gene Expression Profiling of SPOP Knocked Down Cell 30.74
ZRANB2 and SYF2 mediated splicing programs converging on ECT2 are involved in breast cancer cell resistance to doxorubicin 30.47
GATA3-mediated chromatin reprogramming in breast cancer cells 30.22
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming 30.09
Expression profiling of ILC transitional populations and Aiolos accessability and H3K27ac histone modifications in transfected MNK3 cells 29.92
RNA-Seq from human ILC transitional populations 29.92
KLF4 as a rheostat of osteolysis and osteogenesis in prostate tumors in the bone 29.8
Genes altered in expression by Cisplatin treatment in lung cancer cell lines 29.71
RNA-Seq of cKIT+ sorted cells from 16-16.5 week old fetal testes and ovaries and RNA-Seq of TRA-1-60+ H1 hESCs 29.71
Identification of Nrf2 regulated genes by RNA sequencing 29.12
Nrf2 regulated genes in A549 cells 29.12
RUNX1 contributes to higher-order chromatin organization and gene regulation in breast cancer cells. 28.96
RNA-Seq of Kaposi’s sarcoma reveal alterations in glucose and lipid metabolism 28.82
Analysis of Th17 gene signature in the presence of CD28 costimulation in human CD4 naïve T cells 28.64
Highly-motile versus unsorted MDA-MB-231 breast cancer cells 28.42
Genes regulated by SPDEF or FOXA3 in A549 lung carcinoma cells [RNA-seq] 27.91
Gene expression profiling by RNA-seq of SW480 TGM2 knockdown cells 27.14
RNA-Seq analysis of cSCC cells followed by siRNA-induced gene knockdown of AIM2. 26.48
RUNX2/CBFB modulates the response to MEK inhibitors through activation of receptor tyrosine kinases in KRAS mutant colorectal cancer 26.43
Reprogramming postnatal human epidermal keratinocytes toward functional neural crest fates 26.26
Directed differentiation of human embryonic stem cells to corneal endothelial cell-like cells: A transcriptomic analysis 26.25
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation (Ribo-seq, RNA-seq) 26.15
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition 25.99
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition (RNA-seq) 25.99
Characterization of parental and rociletinib-resistant derived H1975 cell lines 25.57
Transcriptional Modulation of Human Endogenous Retroviruses in Primary CD4+ T Cells Following Vorinostat Treatment 25.39
The Genomic Landscape of Atypical Fibroxanthoma 25.34
FOXP3 protects conventional human T cells from premature restimulation-induced cell death 25.05
Next Generation Sequencing (RNA-Sequencing) for the analysis of RUNX3 targets in H460, H460-ERT2-RUNX3 WT and H460-ERT2-RUNX3 MT(K94/171R mutation) 24.85
Genome-wide identification of cancer-specific alternative splicing in circRNA 24.83
CTCF and CohesinSA-1 Mark Active Promoters and Boundaries of Repressive Chromatin Domains in Primary Human Erythroid Cells 24.83
CTCF and CohesinSA-1 Mark Active Promoters and Boundaries of Repressive Chromatin Domains in Primary Human Erythroid Cells [RNA-Seq] 24.83
Characterization of Type I Interferon pathway during Hepatic Differentiation of Human Pluripotent Stem Cells and hepatitis C virus infection 24.81
Differentially expressed genes during pancreatic bud differentiation in cellular aggregates 24.76
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells (mRNA-Seq) 24.69
Integrative analysis identifies targetable CREB1/FoxA1 transcriptional co-regulation as a predictor of prostate cancer recurrence 24.55
Nm-seq finds thousands of modified 2’-O-methylation sites in mRNA with base precision 24.42
RNA-seq in SUNE-1 cells after downregulation of DANCR expression 24.27
Next-generation sequencing analysis of transcriptom in gemcitabine resistant pancreatic cancer cells 24.07
Inducible three-factor direct reprogramming to nephron progenitors using piggyBac transposons 23.96
Functional interactions between Mi-2β and AP1 complexes control response and recovery from barrier disruption 23.32
MCF10A H-Ras RNA-Seq 23.24
Changes in human endometrial gland transcriptome over the window of implantation 23.05
Patient-derived organoids (PDOs) model treatment response of metastatic gastrointestinal cancers. 22.88
NKX2.2 22.79
RNA-Seq analysis of NKX2.2 knockdown in human pancreatic islets 22.79
A genome-wide long noncoding RNA CRISPRi screen identifies PRANCR as a novel regulator of epidermal homeostasis 22.62
Genome-wide Circadian Control of Transcription at Active Enhancers Regulates Insulin Secretion and Diabetes Risk 22.51
Pancreatic Beta Cell Enhancers Regulate Rhythmic Transcription of Exocyst Triggering and Diabetes 22.51
Accurate annotation of human protein-coding small open reading frames 22.43
RNA sequencing analysis of triple cytokine-captured human CD4 T cells 22.27
RNA-Sequencing experiment for effects of PKF115-584 treatment on four T-ALL cell lines (RPMI8402, HPB-ALL, Jurkat, CCRF-CEM). 22.1
The LIN28B/let-7 axis is a novel therapeutic pathway in Multiple Myeloma 21.63
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine 21.51
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine [RNA-Seq] 21.51
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma 21.4
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma [RNA-seq] 21.4
Transcription factors and stress response gene alterations in human keratinocytes following Solar Simulated Ultra Violet Radiation 21.39
NOTCH1 activation in breast cancer confers sensitivity to inhibition of SUMOylation 21.22
Antioxidant metabolism in activated CD8+ T cells regulates stem-like human memory T cell formation and anti-tumor immunity 20.99
Genome-wide expression profiling of an in vitro model for studying esophageal epithelial differentiation 20.87
Transcriptional landscape of epithelial and immune cell populations revealed through FACS-seq of healthy human skin 20.82
Comparing oestrogen-responsive genes in endometrial and breast cancer cell lines 20.78
RNA-seq differential expression studies: more sequence, or more replication? 20.51
NR2F2 study 20.24
Estrogen response in breast cancer cell line MCF-7 is dependent on NR2F2 [RNA-seq] 20.24
Exogenous pyruvate represses histone gene expression to inhibit cancer cell proliferation via the NAMPT-NAD + -SIRT1 pathway 20.21
Combinatorial Regulation Mediated by Biochemically Distinct Forms of SWI/SNF [RNA-Seq] 20.15
Genome-Wide Transcriptional Regulation Mediated By Biochemically Distinct Forms of SWI/SNF 20.15
RNA seq analysis of human Fetal and adult derived Enterospheres 20.14
Genome-wide RNA deep sequencing of CAL-101 or AKTi primed human T cells in comparison to traditionally expanded T cells 20.11
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells (wtRNA-Seq) 20.11
Detection of internal N7-methylguanosine (m7G) RNA modifications by mutational profiling sequencing 20.04
Inhibition of the integrin alpha-V beta-3 reverts the paradoxical effect of levothyroxine replacement during bexarotene therapy in cutaneous T-cell lymphoma 20.01
Disease-associated mutation in SRSF2 misregulates splicing by altering RNA binding affinities 19.99
Cellular acidosis triggers MondoA transcriptional activity by driving mitochondrial ATP production 19.73
The Notch driven long non-coding RNA repertoire in T-cell acute lymphoblastic leukemia 19.51
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors 19.45
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors [RNA-seq] 19.45
RNA-seq analysis in Cornea epithelial cells (CECs), skin epithelial cells (SECs), LSCs after knocking down PAX6 (3-D shPAX6 LSCs) and SESCs transduced with PAX6(3-D PAX6+ SESCs) upon 3-D differentiation 19.41
NEUROD1 dependent gene regulation in murine pancreatic endocrine cells and human stem cell derived insulin producing cells 19.21
Rna-seq transcriptome data for insulin-GFP+ cells differentiated from NEUROD1 knock out and NEUROD1+/+ control human embryonic stem cells. 19.21
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability 19.01
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (22RV1 RNA-seq) 19.01
Combinatorial Reprogramming of Estrogen Signaling by the Nuclear Receptor Family 3C 18.99
RNA-sequencing of formalin fixed human primary melanoma tissue 18.9
Total RNA sequencing of WT intestinal orgaonids. 18.68
Contribution of SRF and Nkx2-5 to androgen-dependent gene expression in prostate cancer 18.58
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on HepG2) 18.53
Transcriptome-wide identification of splicing defects upon XAB2 knockdown 18.49
Regulation of highly expressed hCINAP on translatome 18.24
Genome-wide analysis of herpes simplex virus type 1 (HSV-1) infected cells 18.22
Profiling of circular RNAs in gastric cancer tissues and adjacent normal tissues 18.14
Identifying a novel candidate diagnostic and prognostic biomarker SPRR3 for oral squamous cell carcinoma via mRNA Sequencing and Bioinformatics 18.1
Effect of CHKA knockdown on C4-2 cell transcriptome 18.07
CD161+ Tconv and Treg share transcriptome and display a migratory phenotype which is modified at the inflamed site 17.94
Epigenome regulation during epidermal lineage commitment [ATAC-seq, RNA-seq] 17.94
Paxillin regulates genomic networks in prostate cancer [LNCaP] 17.8
A SRp55-regulated alternative splicing network controls pancreatic beta cell survival and function 17.37
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing [RNA-Seq] 17.22
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing 17.22
Sauchinone controls hepatic cholesterol homeostasis by the negative regulation of PCSK9 transcriptional network 17.18
RNA-seq of YB5 and MCF7 treated with different doses of decitabine 17.17
The flightless I protein is involved in the genome-wide mRNA post-transcriptional regulation in lung carcinoma cells 17.1
Long noncoding RNA LNMAT1 promotes lymphatic metastasis in bladder cancer 16.99
Bladder-cancer-associated mutations in RXRA activate peroxisome proliferator-activated receptors to drive urothelial proliferation 16.98
Bladder cancer associated mutations in RXRA activate peroxisome proliferator-activated receptors 16.98
BACH2 in human plasma cell fate decision 16.98
TCR and inflammatory signals tune human MAIT cells to exert specific tissue repair and effector functions 16.98
Long Non-coding RNA PICSAR Promotes Growth of Cutaneous Squamous Cell Carcinoma by Regulating ERK1/2 Activity 16.79
Expansion, in vivo-ex vivo cycling and genetic manipulation of primary human hepatocytes 16.79
Ribosome queuing enables non-AUG translation to be resistant to multiple protein synthesis inhibitors 16.68
Total RNA was extracted from three samples of CD33 CAR or control T cells from three different donors 16.63
ERK potentiates transactivation and oncogenic function of ERG by phosphorylation induced dissociation of PRC2 complex 16.56
Genome expression analysis of Lung Progenitors matured in the presence of constitutively active or pharmacologically inhibited Glycogen Synthase Kinase 3 16.54
An integrative network biology analysis identifies miR-508-3p as the determinant and a prognosis biomarker of the mesenchymal subtype ovarian cancer 16.48
circRNA profile in hypopharyngeal cancer 16.42
Zone dependent distinctive gene expression profile of the normal human liver tissue 16.33
Gene target specificity of the Super Elongation Complex (SEC) family: How HIV-1 Tat employs selected SEC members to activate viral transcription 16.3
RNA sequencing of human mammary epithelial cells 16.28
DGCR8 acts as a novel adaptor for the exosome complex to degrade double-stranded structured RNAs 16.17
Mitochondrial dsRNA triggers antiviral signalling in humans 16.13
CSL RNA-Seq on HKC and SCC cell lines 16.1
CSL 16.1
Determining effects of microbial metabolite, Urolithin A on colon epithelial cells 16.09
DUX4-induced dsRNA and MYC mRNA Stabilization Activate Apoptotic Pathways in Human Cell Models of Facioscapulohumeral Dystrophy 16.08
Regulating Interleukin-2 activity with engineered receptor signaling clamps 16.01
α Cell Function and Gene Expression Are Compromised in Type 1 Diabetes 16.0
Expression data from fresh human embryonic lung epithelial tip and stalk cells and cultured organoids derived from tip and stalk. 15.96
Single cell RNA-seq resolves lineage-specific activation dynamics of human blood and tissue T cells 15.86
RNA-Seq analysis of human Tr1, Tregs and IL10neg cells 15.82
SnapShot-Seq: a method for extracting genome-wide, in vivo mRNA dynamics from a single total RNA sample 15.79
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [K562] 15.77
Transcriptome analysis reveals malignant and hypoxic signature of glioblastoma 15.72
Profiles of Long Noncoding RNAs in Human Naive and Memory T Cells 15.61
Gene expression profile of human multiple myeloma cell line MM.1S after knockdown of KDM6B 15.5
Cancerous inhibitor of PP2A (CIP2A) Constrains Th17 Differentiation by Modulating STAT3 Signaling 15.46
A single cell reference map for human blood and tissue T cell activation 15.27
Time series single-cell transcriptomic analysis of AEC2 directed differentiation 15.26
RNA seq_A375 gSMARCB1 + A549 etoposide, Aurora kinases inhibitors treated 15.23
High-throughput RNA sequencing on circular RNA profiles of human bladder cancer tissues and normal bladder tissues 15.22
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 15.14
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 [RNA-seq] 15.14
MondoA Links Muscle Lipid Accumulation and Insulin Resistance Driven by Nutrient Overload 15.03
Transcriptome profiling in primary human skeletal myotubes with MondoA knockdown 15.03
Expression profiling and occupancy after knockdown or over-expression of HFN1A or HNF4G in prostate cancer cells 15.02
Single Cell RNA-Sequencing Identifies Diverse Roles of Epithelial Cells in Idiopathic Pulmonary Fibrosis 14.99
Epigenome regulation during epidermal lineage commitment [RNA-seq] 14.97
Quantitative mass spectrometry-based proteomics reveals the dynamic protein landscape during initiation of human Th17 cell polarization 14.9
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression 14.87
Epigenetic silencing of the tumor suppressor RASSF4 favors multiple myeloma progression 14.66
LSD1 pharmacological inhibition in SET-2 containing wild type and mutant LSD1 [RNA-Seq] 14.64
LSD1 pharmacological inhibition in SET-2 containing wild type and mutant LSD1 14.64
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with tcons_00001221 shRNA or control shRNA 14.57
Endothelial Cells Control Pancreatic Cell Fate at Defined Stages through EGFL7 Signaling 14.5
Profiling and bioinformatics analyses reveal differential expression of circular RNA in tongue cancer revealed by high-throughput sequencing 14.45
Transcriptome profiling of CXCR2+ neuroendocrine (NE) tumor cells purified from patients' fresh prostate adenocarcinoma 14.44
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 1: RNA-seq) 14.35
RNA-sequencing of isogenic primary, pre-malignant immortalized, and Ras-transformed human mammary epithelial cells 14.24
Characterization of human ILC2 subsets 14.18
Identification of global regulators of T-helper cell lineage specification 14.18
Identification of global regulators of T-helper cell lineage specification (RNA-Seq) 14.18
Distinct epigenomes in CD4+ T cells of newborns, middle-ages and centenarians. 14.12
Integrative analysis of mRNA and lncRNA profiles identified pathogenetic lncRNAs in esophageal squamous cell carcinoma 13.97
The NFkB subunit RELA is a master transcriptional regulator of the committed epithelial-mesenchymal transition in airway epithelial cells 13.92
Transcriptome splicing analysis in K562 cells expressing rare and private spliceosomal mutations 13.82
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells 13.71
RNA sequencing of 13 T-cell acute lymphoblastic leukemia patients (5 TCRAD-MYC translocated T-ALL_8TAL1-LMO2 T-ALL) 13.68
Combined inhibition of STAT3 and DNA repair in palbociclib-resistant ER-positive breast cancer 13.53
Non-coding regions are the main source of tumor-specific antigens 13.41
Non-coding regions are the main source of tumor-specific antigens [human] 13.41
Effect of hypoxia and TGFβ1 on gene expression in HPF fibroblast cells 13.24
RNA sequencing for lncRNA, miRNA and mRNA expression analysis in human laryngeal cancer 13.16
Connexin 32-mediated cell-cell communication is essential for hepatic differentiation from human embryonic stem cells 13.07
BASP1 modifies the Tamoxifen response 13.04
Divergent expression and metabolic functions of human glucuronosyltransferases through alternative splicing 13.01
Gene expression profiling in two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 13.0
Two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 13.0
Gene expression profiles of 4-1BB+PD-1-high, 4-1BB-PD-1-high, and PD-1-int tumor-infiltrating CD8 T cells in hepatocellular carcinoma 12.88
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition 12.86
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition [RNA-Seq] 12.86
NF-κB p65 dimerization and DNA-binding is important for inflammatory gene expression 12.74
LIN28A Over-expression RNAseq 12.72
Cooperation of Nutlin-3a and a Wip1 inhibitor to induce p53 activity 12.69
Runx1 stabilizes the mammary epithelial cell phenotype and prevents epithelial to mesenchymal transition 12.62
RNA-seq analysis of human KMT2A rearranged MV4;11 AML cell line treated with DOT1L and/or EZH2 inhibitor 12.61
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures [RNA-Seq] 12.58
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures 12.58
The transcriptomic differences between Th1, Tr1, and Tneg cells in controlled human malaria infection 12.51
Modeling the MYC-driven normal-to-tumour switch in breast cancer. 12.48
Estrogen Receptor Beta Impacts Hormone-Induced Alternative mRNA Splicing in Breast Cancer Cells 12.41
Genes encoding cognate receptors for IRI-related recipient cytokines are expressed in donor livers 12.36
Human iPSC derived glomeruli facilitate accurate modelling of podocytopathy 12.36
Different Temporal Effects of Ebola Virus VP35 and VP24 Proteins on Global Gene Expression in Human Dendritic Cells 12.35
Gene expression changes after depletion of Cyclin F and atypical E2Fs in HeLa cells. 12.32
Effects of plasticizers (bisphenol A, bisphenol AF) and an herbicide in MCF7 human breast cancer cells 12.29
Dissection of estrogen receptor alpha signaling pathways in osteoblasts using RNA-sequencing 12.27
Transcriptional effect of ETV1 knockdown in melanoma cells 12.15
Biosynthesis of histone messenger RNA employs a specific 3' end endonuclease 12.07
mRNA-Seq profiling of human developing kidney 12.05
naive T cell heterogeneity after neonatal thymectomy 11.82
Modulation of Indoleamine 2, 3-dioxygenase 1 Expression by Activated Human T cells in Breast Cancer Cells is Controlled by DNA Promoter Methylation 11.75
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export 11.72
Epigenome regulation during epidermal lineage commitment 11.64
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress [human] 11.37
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress 11.37
The inhibitory effect of TIAM1 on TAZ transcriptional activity and TIAM1 differentially expressed genes 11.27
List of TIAM1 differentially expressed genes in SW620 cells [RNA-seq] 11.27
Long noncoding RNA ROCR contributes to SOX9 expression and chondrogenic differentiation of human mesenchymal stem cells 11.13
RNA-seq of Human neck of femur (NOF) fracture hip and osteoarthritic (OA) cartilage 11.13
RNA-seq of human aneuploid cell lines with Trisomy 21 11.02
Targets of ROR2 overexpression in MCF-7 cells revealed a differentially regulated module of non-canonical WNT signaling pathway 10.96
Gene expression patterns define the hepatocyte-like cells derived by different strategies [RNA-seq] 10.93
Gene expression patterns define the hepatocyte-like cells derived by different strategies 10.93
RNA-Seq Analysis of Anacardic Acid Treated MCF7 and MDA-MB-231 Breast Cancer Cell Lines 10.86
KDM1A confers invasive and metastatic attributes in lung adenocarcinoma by modulating a non-canonical Integrin ß3-KRAS signaling pathway 10.83
Biased Expression of the FOXP3Δ3 Isoform in Aggressive Bladder Cancer Mediates Differentiation and Cisplatin Chemotherapy Resistance 10.75
mRNA sequencing of oropharyngeal cancer cell lines 10.71
Allergen-specific immunotherapy modulates the balance of circulating Tfh and Tfr cells 10.69
Comparative total RNA and mRNA sequencing and systems analysis reveals nascent transcriptional response to early HIV-1 infection in a CD4+ T cell line 10.62
A comparison of gene expression between lesional and non-lesional derived keratinocytes of Hailey-Hailey disease patients. 10.61
Neurofibromin is an Estrogen Receptor alpha Transcriptional Co-repressor in Breast cancer 10.53
Leucegene: ALL sequencing 10.4
Targeting HuH7 cells with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 10.35
Differential responses by human respiratory epithelial cell lines to respiratory syncytial virus reflect distinct patterns of infection control 10.31
Transcriptome profiles of moderate dysplasia in oral mucosa associated with malignant conversion 10.18
Impact of library preparation on downstream analysis and interpretation of RNA-seq data: comparison between Illumina PolyA and NuGEN Ovation protocol 10.16
RNA-seq of IL-4 stimulated human keratinocytes 10.12
Hyper-activation of HUSH complex function by Charcot-Marie-Tooth disease mutation in MORC2 10.07
Time-dependent regulation of cellular programming of monocytes by NCOR2 [RNASeq_KD] 10.02
Modeling Trilateral Retinoblastoma using Human Embryonic Stem Cells 10.0
Sequencing-based analyses characterize a tumor suppressive role of mir-1271 repressed by DNA hypermethylation in gastric cancer 9.94
Gene expression profiles of BxPC-3, MiaPaCa-2 and PANC-1 cell lines treated with DMSO and THZ1 respectively 9.91
RNA-Seq analysis and comparison of corneal epithelium in keratoconus and myopia patients 9.89
Neuronal Development And The Onset Of Electrical Activity In The Human Enteric Nervous System 9.78
Ribosome profiling of A549 cells depleted of RPLP1 and RPLP2 and infected with DENV. 9.72
Integrated Profiling of mRNAs and microRNAs to Identify Potential Biomarkers for Oral Malignant Transformation [mRNA-Seq] 9.7
Integrated Profiling of mRNAs and microRNAs to Identify Potential Biomarkers for Oral Malignant Transformation 9.7
Identification of long noncoding RNAs regulated by p53 9.69
Conserved roles for murine mDUX and human DUX4 in activating cleavage stage genes and MERVL/HERVL retrotransposons [RNA-Seq] 9.67
Genome-wide modelling of transcription kinetics reveals patterns of RNA processing delays 9.66
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 1] 9.59
Expression profiles of long non-coding RNAs located in autoimmune disease-associated regions reveal immune cell type specificity 9.43
Long non-coding RNA profiling of human lymphoid progenitors reveals transcriptional divergence of B cell and T cell lineages 9.42
Homolog-selective degradation as a strategy to probe the function of CDK6 in AML 9.4
Potential signaling pathways and gene signatures associated with brain metastases in NSCLC patients 9.36
Discovery and verification of liver cancer marker genes and variable scission based on second-generation sequencing data analysis 9.34
The mRNA export receptor NXF1 coordinates transcriptional dynamics, alternative polyadenylation and mRNA export 9.31
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours 9.09
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours [RNA-seq] 9.09
TGF-β regulation of miRNA expression in pancreatic cancer 8.97
NSD2 overexpression links drives clustered chromatin and transcriptional changes in a subset of insulated domains of insulated domains 8.75
Acetylation-Dependent Control of Global Poly(A) RNA Degradation by CBP/p300 and HDAC1/2 8.57
RNA-Seq data for five HER2 over-expressed samples with twelve green fluorescent protein control samples using human mammary epithelial cells 8.56
The LRF/ZBTB7A transcription factor is a BCL11A-independent repressor of fetal hemoglobin 8.54
Primary human trophoblast from term placenta 8.54
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells 8.52
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells (RNA-Seq) 8.52
Functional separation of IL7Rα/KLRG1-defined CD8+ T cell populations in humans 8.5
NOTCH signaling is activated in and contributes to resistance in enzalutamide-resistant prostate cancer cells 8.31
Inhibiting the oncogenic translation program is an effective therapeutic strategy in multiple myeloma 8.23
Reprogrammed myeloid cell transcriptomes in NSCLC 8.18
Tracking transcriptional changes in a species-specific manner during experimental hepatoblastoma progression in vivo 8.16
The contribution of adenosine receptor 3-mediated signaling to TLR4-induced responses by human dendritic cells 8.11
RNA-seq and flow-cytometry of conventional, scalp, and palmoplantar psoriasis reveal shared and distinct molecular pathways 8.06
Low carbohydrate diet study for non-alcoholic fatty liver disease patients 8.0
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and SMAD4 Y95 Mutation Transcriptomes 7.75
Antiviral innate immunity of hepatitis C virus-infected stem cell-derived hepatocytes 7.71
Quantitative Proteomics Reveals a Unique Wiring of Signaling Pathways that Protects Human Regulatory T Cell Identity 7.68
The dynamics of cellular response to therapeutic perturbation using multiplexed quantification of the proteome and transcriptome at single-cell resolution 7.66
p63 controls the enhancer landscape during keratinocyte differentiation 7.34
The circadian transcriptional landscape in primary human mammary epithelial cells 7.21
Human antimicrobial cytotoxic T lymphocytes, defined by NK receptors and antimicrobial proteins, kill intracellular bacteria 7.08
Low-dose decitabine priming endows CAR T cells with enhanced and persistent anti-tumor potential by epigenetic reprogramming 7.04
Wnt1 silences CC/CXC motif chemokine genes in dendritic cells and induces adaptive immune resistance in lung adenocarcinoma 6.81
MCF-7 as a model for functional analysis of breast cancer risk variants 6.64
Analysis of gene expression in primary human foreskin keratinocytes +/- HPV16 E7 or PTPN14 knockout 6.54
RNA-Seq of human PDA cell lines transfected with control siRNA or Pdx1 siRNA 6.52
RNA-sequencing with micro-dissected boundary organoid into anterior, posterior, and boundary regions 6.43
RNA-Seq in human T-cell lymphoblastic lymphoma samples and control thymuses 6.22
Human T-cell lymphoblastic lymphoma samples and control thymuses 6.22
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination 6.07
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination (RNAseq) 6.07
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 5.95
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 5.95
Sequence dependency and regulatory function of dimeric NOTCH1/RBPJ complexes on coding and non-coding transcription in T-lymphoblastic leukemia 5.56
p63 establishes epithelial enhancers de novo at critical craniofacial development genes 5.47
Expression profiling of converted and control dermal BJ fibroblasts 5.47
Transcriptome of activated human and mouse MAIT cells 5.45
RAID allows multiplexed quantification of intracellular (phospho-)proteins and transcriptomes from fixed single cells 5.28
Specific molecular signatures underlie response to decitabine in CMML [RNA-seq] 5.23
Specific molecular signatures underlie response to decitabine in CMML 5.23
Evolution of an lncRNA leads to a primate specific modulation of alternative splicing 5.16
Loss of ANCO1 repression of AIB1/YAP drives breast cancer progression 5.12
Human islets of varying quality: the good, the (not so) bad and the ugly 5.1
Defective transcription elongation in a subset of cancers confers immunotherapy resistance (BGI12 RNA-Seq) 4.93
Fra-1 is a key driver of colon cancer metastasis and a Fra-1 classifier predicts disease-free survival 4.91
Selective silencing of euchromatic L1s revealed by genome-wide screens for L1 regulators 4.9
A cell cycle-based functional screen to identify lncRNA-based cancer biomarkers 4.84
SIGNAL INTEGRATION AND TRANSCRIPTIONAL REGULATION OF THE INFLAMMATORY RESPONSE MEDIATED BY THE GM-/M-CSF SIGNALING AXIS IN HUMAN MONOCYTES [RNA-seq] 4.78
SIGNAL INTEGRATION AND TRANSCRIPTIONAL REGULATION OF THE INFLAMMATORY RESPONSE MEDIATED BY THE GM-/M-CSF SIGNALING AXIS IN HUMAN MONOCYTES 4.78
Genomic profiling of biliary tract cancer cell lines reveals molecular subtypes and actionable drug targets 4.78
PolyA-sequencing in IMR-32 cells treated with THZ531 or DMSO 4.78
Transcriptome analyses of human pancreatic islets and pseudoislets 4.76
Splicing and gene expression changes in human mammary epithelial MCF-10A cells expressing SR or SR-like proteins 4.74
Combined MEKi (GDC-0973) and WNT (G007-LK) treatment in APC and KRAS mutant HCT-15 cell line 4.63
PTHrP overexpression in MCF7 cells 4.62
Differential Gene Expression between MCF10A and MCF7 cells 4.56
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth 4.47
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth [RNA-Seq] 4.47
Dynamic 3D chromosomal landscapes in acute leukemia [RNA-Seq] 4.47
Dynamic 3D chromosomal landscapes in acute leukemia 4.47
Transcriptome analysis reveals differential splicing events in IPF lung tissue 4.41
Loss of endometrial plasticity in recurrent pregnancy loss 4.38
Loss of endometrial plasticity in recurrent pregnancy loss (RNA-Seq) 4.38
Pluripotent stem cell model of Nakajo-Nishimura syndrome untangles proinflammatory pathways mediated by oxidative stress 4.24
RNA-Seq analysis of Head and Neck Squamous cell carcinoma cell-lines 4.19
Androgen receptor programming in human tissue implicates HOXB13 in prostate pathogenesis [RNA-Seq] 3.98
Androgen receptor programming in human tissue implicates HOXB13 in prostate pathogenesis 3.98
Role of OSGIN1 in Mediating Smoking-induced Autophagy in the Human Airway Epithelium [RNA-Seq] 3.96
Role of OSGIN1 in Mediating Smoking-induced Autophagy in the Human Airway Epithelium 3.96
RNA sequencing of human pancreatic cancer cell lines 3.96
Smoking Dysregulates the Human Airway Basal Cell Transcriptome at COPD-linked Risk Locus 19q13.2 3.88
Persistence of stem cell metabolism in cancers as a failure of differentiation 3.83
Cis-Regulatory Circuits Regulating NEK6 Kinase Overexpression in Transformed B Cells Are Super-Enhancer-Independent (RNA-seq) 3.8
Cis-Regulatory Circuits Regulating NEK6 Kinase Overexpression in Transformed B Cells Are Super-Enhancer-Independent 3.8
Identification of long noncoding RNAs in T-ALL cell lines 3.77
Cutaneous Immunoprofile of Three Spotted Fever Group Rickettsiosis 3.77
Subclonal cooperation drives metastasis through modulating local and systemic immune microenvironments 3.72
Gene expression analysis of breast cancer cell-lines 3.7
Gene expression and genome-wide location analysis of breast cancer cell-lines 3.7
Gene expression profiles of PD1-high, PD1-intermediate, and PD1-negative tumor-infiltrating CD8 T cells in hepatocellular carcinoma 3.67
Paclitaxel plus Cirmtuzumab Achieves Greater Clearance of Patient-derived Xenografts By Targeting ROR1+ Breast Cancer Stem Cells 3.64
Transcriptome analysis of RANK-positive and RANK-negative luminal progenitor subpopulations in the human breast 3.56
Transcriptome analysis of the HepG2 cells expressing hepatic transcription factors 3.49
Transcriptional changes in pancreatic cancer cells associated with gemcitabine resistance 3.48
Expression and functions of long noncoding RNAs during human T helper cell differentiation 3.48
The transcriptomic landscape of MAIT cell development in the thymus (NN41 RNAseq data set) 3.26
Select correlative genes involved in pathogenesis of idiopathic interstitial pneumonia by high-throughput sequencing analysis 3.01
CNOT1 and Transcriptomic Landscape of a HeLa Cell Line 2.88
Polycomb complexes associate with enhancers to promote oncogenic transcriptional programs in cancer 2.87
Transcriptomic profile of intestinal epithelial cells obtained from ileal endoscopic biopsies from newly-diagnosed, pediatric Crohn's disease patients and healthy controls. 2.79
Analysis of HPV16 E2 host gene expression using TERT immortalized keratinocytes (NOKs) cell lines and RNA-sequencing 2.74
Dysregulated immune system networks in war veterans with PTSD 2.44
Group A Streptococcus M1T1 Intracellular Infection of Primary Tonsil Epithelial Cells Dampens Levels of Secreted IL-8 Through the Action of SpyCEP 2.41
Reconstitution of the human pancreatic niche stimulates differentiation of hESCs into beta cells and reveals new signals for pancreatic endocrine cell maturation 2.33
Dexamethasone inhibits respiratory syncytial virus-driven mucus production while increasing viral replication without altering antiviral interferon signaling 2.31
A Low-cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-relevant Subtypes: Singapore Cohort RNA-seq 2.28
A Low-cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-relevant Subtypes 2.28
Gene expression profiling of patient's DCIS-IDC tandem lesions by RNA sequencing analysis 2.2
Whole blood RNAseq from Generalised Pustular Psoriasis patients and healthy individuals 2.19
Gene expression profile of regenerated CD8αα T cells and CD8αβ T cells from LMP2 T-iPSCs 2.03
Gene Expression Profiling of Cutaneous CD30+ Lymphoproliferative Disorders by RNA-seq 1.98
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 [3mRNA-seq] 1.91
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 1.91
Transcriptome analysis of eosinophilic and noneosinophilic chronic rhinosinusitis with nasal polyps reveals distinct lncRNA expression profiles 1.9
Altered Hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways 1.83
Altered Hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways [RNA-seq] 1.83
Organoids derived from directly reprogrammed human hepatocytes for modeling liver cancer initiation 1.64
Human Adult Sorted Live Cell Erythroblasts RNA-Seq. 1.59
RNA-seq analysis in knockdown Jurkat samples for each factor of TAL1 complex 1.4
Oncogenic roles of ARID5B in T-ALL 1.4
Genome wide impact of loss of mechanoluminal stimulation on neonatal intestine 1.37
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq Cell lines] 1.25
RNA-seq analysis identifies different transcriptomic types and developmental trajectories of primary melanomas 1.25
RUVBL1/RUVBL2 ATPase Activity Drives PAQosome Maturation, DNA Replication and Radioresistance in Lung Cancer 1.23
Activating Transcription Factor 4 modulated TGFb-induced aggresiveness in triple negative breast cancer vis SMAD2/3/4 and mTORC2 signaling 1.22
Priming mobilization of hair follicle stem cells triggers permanent loss of regeneration after alkylating chemotherapy 1.2
Oncolytic reactivation of KSHV as a therapeutic approach for primary effusion lymphoma: RNA-sequencing of PEL cell lines during KSHV reactivation 1.2
JAG1 Mediated Notch Signaling Regulates Secretory Cell Differentiation of the Human Airway Epithelium 1.15
CDK12 regulates alternative last exon mRNA splicing and promotes invasion of a breast cancer cell line 1.11
Anti-Inflammatory Effects of Budesonide in Human Fetal Lung 1.07
Gene expression in mature and immature human ES-derived beta cells, and sorted beta-cells from adult islets 1.06
Gene expression of collecting duct carcinoma of the kidney 1.01
RNA sequencing of Asthmatic Human Airway Smooth Muscle Cells II 0.96
Pan-cancer transcriptomic analysis associates long non-coding RNAs with key mutational driver events 0.96
Integrated Multi-omic Analysis of Esthesioneuroblastomas Identifies Two Subgroups Linked to Cell Ontogeny 0.81
Immunophenotyping and Transcriptomic Outcomes in PDX-Derived TNBC Tissue 0.8
Transcriptional response of human endocervical epithelial A2EN cells to infection with wild-type or CpoS-deficient Chlamydia trachomatis L2/434/Bu 0.73
Epigenome Editing by CRISPR/Cas9 Repressors for Silencing of Distal Regulatory Elements 0.7
HIV Reprograms Human Airway Basal Stem/Progenitor Cells to Acquire a Tissue Destructive Phenotype 0.63
RNA-Seq analysis of cSCC cells after siRNA-induced gene knockdown of lncRNA PRECSIT 0.58
THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors 0.58
ML29755 RNA-seq data 0.5
The lung-enriched p53 mutants V157F and R158L/P regulate a novel transcriptome in lung cancer 0.5
Expression profile of MM.1S tumors folloiwing treatment with bortezomib 0.48
RNA sequencing of Asthmatic Human Airway Smooth Muscle Cells I 0.35
Gene expression analysis in response to hypoxic pathway inhibition 0.29
RNA-sequencing of healthy human skeletal myocytes 0.2
Dual RNA-seq of diverse human, mouse and pig cell-types infected with various Salmonella strains 0.2
Dual RNA-seq – High-resolution comparative Dual RNA-seq time-course 0.2
Sequencing of ponatinib-resistant LC-2/ad derivatives (PR1 and PR2) and parental LC-2/ad cells 0.15
RNASeq of Arg2 gRNA or scrambled gRNA CRISPR'd Tregs 0.14
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles 0.09
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles (RNA-seq) 0.09
Maturing an Enteric Nervous System in Human Intestinal Organoid-derived Tissue-Engineered Small Intestine 0.07


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation